✦ LIBER ✦

Benign prostatic hyperplasia in an XX man

✍ Scribed by M.J. Marinello; W. Montes; W.E. Farnsworth; D. Hare; B. Fisher; R.M. Bannerman

Book ID: 119043862
Publisher: Elsevier Science
Year: 1979
Tongue: English
Weight: 987 KB
Volume: 13
Category: Article
ISSN: 0090-4295
DOI: 10.1016/0090-4295(79)90387-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Benign prostatic hyperplasia in XX man

✍ C. Dimopoulos; V. Jannopoulos; N. Goulandris 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Benign prostatic hyperplasia: an overvie

Benign prostatic hyperplasia: an overview

✍ Ziada, Ali (author);Rosenblum, Mark (author);Crawford, E. David (author) 📂 Article 📅 1999 🏛 Elsevier Inc. 🌐 English ⚖ 111 KB

Benign prostatic hyperplasia: an overvie

Benign prostatic hyperplasia: an overview

✍ Ziada, Ali (author);Rosenblum, Mark (author);Crawford, E. David (author) 📂 Article 📅 1999 🏛 Elsevier Inc. 🌐 English ⚖ 111 KB

CHRONIC PROSTATITIS IN BENIGN PROSTATIC

CHRONIC PROSTATITIS IN BENIGN PROSTATIC HYPERPLASIA

✍ E. O. Odunjo; E. A. Elebute 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 912 KB

Chromosome abnormalities in benign prost

Chromosome abnormalities in benign prostatic hyperplasia

✍ Magdy S. Aly; Paola Dal Cin; Herman Van Den Berghe; Wim Van De Voorde; Hein Van 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 503 KB

We combined conventional cytogenetic analysis and fluorescence in situ hybridization of short-term cultures of 28 samples from benign prostatic hyperplasia. Lou of the Y chromosome was the most common chromosome change, followed by trisomy 7. Trisomy 7, however, may be unrelated to the origin of be

An appraisal of telomerase activity in b

An appraisal of telomerase activity in benign prostatic hyperplasia

✍ E. Caldarera; N.H. Crooks; G.H. Muir; M. Pavone-Macaluso; P.L. Carmichael 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB 👁 2 views

## Background: Prostate cancer is one of the commonest neoplasms in elderly males in developed countries. it is not clear which individuals are at high risk of developing aggressive adenocarcinoma of the prostate. biomarkers are therefore urgently needed to identify such individuals. it had been su